Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
Seamless Therapeutics uses programmable recombinase technology to perform large, precise DNA edits anywhere in the human genome without introducing additional mutations. The company is developing a pipeline of disease-modifying gene editing therapies to address the genetic causes of severe diseases across a broad range of indications.
Parse Score